GSK1838705A 是一种小分子激酶抑制剂,能够抑制 IGF-IR 和胰岛素受体,其 IC50 分别为 2.0 和 1.6 纳摩尔/升。
顾客使用 Adooq 产品发表的高质量科研文献
Adooq用户使用GSK1838705A发表的1篇文献
生物活性
| Discription | GSK1838705A is a small-molecule kinase inhibitor that inhibits IGF-IR and the insulin receptor with IC50s of 2.0 and 1.6 nmol/L, respectively. |
||
|---|---|---|---|
| Targets |
|
产品信息
| 目录号 | A11175 |
|---|---|
| 分子式 | C27H29FN8O3 |
| 分子量 | 532.57 |
| CAS号 | 1116235-97-2 |
| SMILES | CNC(=O)C1=C(C=CC=C1F)NC2=NC(=NC3=C2C=CN3)NC4=C(C=C5CCN(C5=C4)C(=O)CN(C)C)OC |
| 其他名称 | GSK-1838705A |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
溶解性数据
| In vitro (25°C) | DMSO | 103 mg/mL (193.4 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
| In vivo | 15% Captisol+citrate vehicle | 28 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
Preparing Stock Solutions
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 18.78 mL | 93.88 mL | 187.77 mL |
| 0.5 mM | 3.76 mL | 18.78 mL | 37.55 mL |
| 1 mM | 1.88 mL | 9.39 mL | 18.78 mL |
| 5 mM | 0.38 mL | 1.88 mL | 3.76 mL |
Useful Calculator
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
Keywords: 购买 GSK1838705A | GSK1838705A 供应商 | GSK1838705A 花费 | GSK1838705A 生产商 | 订购 GSK1838705A | GSK1838705A 代理商
| 购买 1116235-97-2 | 1116235-97-2 供应商 | 1116235-97-2 花费 | 1116235-97-2 生产商 | 订购 1116235-97-2 | 1116235-97-2 代理商

















